Clinical trial
Prospective Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder
NCT02468830 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder
- Lead sponsor
- CHU de Quebec-Universite Laval
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- March 31, 2016
- Enrollment
- 58 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder, urinary incontinence